Isaac Bright, CEO at RubrYc Therapeutics, talks to Andy Burrows of KNect365 Life Sciences after winning the top prize in the Xcelerate Startup Pitch Competition hosted by EBD Group and Xcelerate Insight during Biotech Week Boston in September, 2018. RubrYc is a bio therapeutics discovery company working on mining drug: target interfaces to build better therapies. Currently, they are seeking $50 million for a B-round. The pitch competition is designed to give early stage companies exposure to possible investors and partners, and is judged by top venture capitalists and industry experts. The company won a free pass to next year’s Xcelerate event.